Acerca de

ERA220144_illustratie 1920x1080.png

Program

08.45-09.20

09.20-09.30

09.30-10.00

10.00-10.15

10.15-10.45

10.45-11.00

11.00-11.20

11.20-11.40

11.40-12.10

12.10-12.30

12.30-12.40

12.40-13.40

13.40-14.10

14.10-14.40

14.40-14.50

14.50-15.10

15.10-15.30

15.30-15.45

15.45 

Registration 

Welcome & Introduction H.L.A. Janssen

Portal hypertension: Baveno VII and beyond Chair S. Darwish Murad

Beta blockade all patients with portal hypertension? C. Ripoll

Statins for all patients with cirrhosis? R. Maan 

Treatment of hepatic encephalopathy beyond lactulose J.G. Langendonk

Secondary prophylaxis for SBP with noroxin or rifaximin R.B. Takkenberg

Discussion 

Coffee break

State of the art lectures part 1 Chair M.J. Sonneveld

Porto-sinusoidal vascular disorder: a new name for an old disease P.E. Ratou

When to start and when to stop nucleo(s)tide analogues in chronic hepatitis B H.L.A. Janssen

Discussion

Lunch

State of the art lectures part 2 Chair R.J. de Knegt

Steroids in alcoholic hepatitis: yes, no or with antibiotics? A. Louvet

New pharmacological therapies for NAFLD/NASH, all diabetics with NASH on GLP-1? S. Francque

Discussion

Liver tumors Chair R.A. de Man

HCC surveillance; imaging, AFP and beyond D. Sprengers

Liver transplantation for perihilar cholangiocarcinoma: indication and outcome R.J. Porte

Discussion and closing remarks H.L.A. Janssen

Drinks